Applied Stock Analysis

AGTC
 Stock
  

USD 0.28  0.02  6.67%   

The big decline in price over the last few months for Applied Genetic Tech could raise concerns from investors as the firm is trading at a share price of 0.28 on 996,922 in volume. The company executives failed to add value to investors and position the firm supply of money to exploit market volatility in August. However, diversifying your holdings with Applied Genetic Tech or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.98. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Applied Genetic partners.
Please continue to Trending Equities.
  
The Applied Genetic stock analysis report makes it easy to digest most publicly released information about Applied Genetic and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Applied Stock analysis module also helps to analyze the Applied Genetic price relationship with some important fundamental indicators such as market cap and management efficiency.

Applied Stock Analysis Notes

About 34.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.19. Some equities with similar Price to Book (P/B) outperform the market in the long run. Applied Genetic Tech recorded a loss per share of 2.27. The entity had not issued any dividends in recent years. Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Applied Genetic Technologies Corporation was incorporated in 1999 and is headquartered in Alachua, Florida. Applied Genetic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 83 people. For more info on Applied Genetic Tech please contact Susan Washer at 386 462 2204 or go to https://agtc.com.

Applied Genetic Tech Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Applied Genetic's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Applied Genetic Tech or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Applied Genetic Tech generated a negative expected return over the last 90 days
Applied Genetic Tech has high historical volatility and very poor performance
Applied Genetic Tech has some characteristics of a very speculative penny stock
Applied Genetic Tech has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 500 K. Net Loss for the year was (62.69 M) with loss before overhead, payroll, taxes, and interest of (22.58 M).
Applied Genetic Tech currently holds about 67.85 M in cash with (60.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from www.accesswire.com: Gold River Productions, Inc Announces It Has Acquired 100 percent of Trans American Aquaculture, LLC - a Texas-based, Land-Based World Class Integrated Aquaculture Business Specializing in Shrimp Production and Shrimp Genetics - AccessWire

Applied Genetic Tech Upcoming and Recent Events

Earnings reports are used by Applied Genetic to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Applied Genetic previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report10th of February 2022
Next Financial Report16th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End22nd of September 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Applied Genetic SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Applied Genetic prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Applied Genetic investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Applied Genetic Tech specific information freely available to individual and institutional investors to make a timely investment decision.
26th of August 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
12th of August 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
14th of July 2022
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement
View
10th of June 2022
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
View
16th of May 2022
Financial Statements and Exhibits. Regulation FD Disclosure
View
9th of May 2022
Financial Statements and Exhibits. Entry into a Material Definitive Agreement
View
23rd of March 2022
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement
View
2nd of March 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View

Applied Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Applied Genetic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Applied Genetic Tech backward and forwards among themselves. Applied Genetic's institutional investor refers to the entity that pools money to purchase Applied Genetic's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon SharesM1.5 M
Portolan Capital Management LlcCommon Shares1.6 M1.2 M
Millennium Management LlcCommon Shares1.5 M1.2 M
Interwest Venture Management CoCommon Shares1.4 M1.1 M
Blackrock IncCommon Shares923.9 K711 K
Sabby Management LlcCommon Shares812 K625 K
Geode Capital Management LlcCommon Shares679.5 K523 K
Note, although Applied Genetic's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Applied Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 12.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Applied Genetic's market, we take the total number of its shares issued and multiply it by Applied Genetic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (35.87) % which means that it has lost $35.87 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (87.06) %, meaning that it created substantial loss on money invested by shareholders. Applied Genetic management efficiency ratios could be used to measure how well applied genetic tech manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 28th of September, Applied Genetic shows the mean deviation of 4.19, and Risk Adjusted Performance of (0.08). Applied Genetic Tech technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Applied Genetic Tech, which can be compared to its rivals. Please confirm Applied Genetic Tech information ratio and the relationship between the maximum drawdown and skewness to decide if Applied Genetic Tech is priced correctly, providing market reflects its regular price of 0.29 per share. As Applied Genetic Tech appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Applied Genetic Tech Price Movement Analysis

Study
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Applied Genetic Tech price series.
.

Applied Genetic Tech Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Applied Genetic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Applied Genetic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Applied Genetic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Doyleygay Hope over a month ago via Macroaxis 
Acquisition by Doyleygay Hope of 147900 shares of Applied Genetic subject to Rule 16b-3
Stephen Potter over two months ago via Macroaxis 
Sale by Stephen Potter of 8070 shares of Applied Genetic
Reynolds Gerald Anthony over three months ago via Macroaxis 
Sale by Reynolds Gerald Anthony of 94 shares of Applied Genetic
Doyleygay Hope over six months ago via Macroaxis 
Acquisition by Doyleygay Hope of 180000 shares of Applied Genetic subject to Rule 16b-3
Scaria Abraham over six months ago via Macroaxis 
Acquisition by Scaria Abraham of 220000 shares of Applied Genetic subject to Rule 16b-3
Hashad Yehia over six months ago via Macroaxis 
Acquisition by Hashad Yehia of 14000 shares of Applied Genetic subject to Rule 16b-3
Schneider Susan over six months ago via Macroaxis 
Acquisition by Schneider Susan of 180000 shares of Applied Genetic subject to Rule 16b-3
Krol Patrick Johan Hendrik over six months ago via Macroaxis 
Purchase by Krol Patrick Johan Hendrik of 2544 shares of Applied Genetic
Lieber Jonathan I over a year ago via Macroaxis 
Acquisition by Lieber Jonathan I of 202000 shares of Applied Genetic subject to Rule 16b-3
Hashad Yehia over a year ago via Macroaxis 
Acquisition by Hashad Yehia of 25000 shares of Applied Genetic subject to Rule 16b-3
Stephen Potter over a year ago via Macroaxis 
Payment of 5724 shares by Stephen Potter of Applied Genetic subject to Rule 16b-3
Reynolds Gerald Anthony over a year ago via Macroaxis 
Acquisition by Reynolds Gerald Anthony of 34500 shares of Applied Genetic subject to Rule 16b-3

Applied Genetic Predictive Daily Indicators

Applied Genetic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Applied Genetic stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Applied Genetic Forecast Models

Applied Genetic time-series forecasting models is one of many Applied Genetic's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Applied Genetic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Applied Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Applied Genetic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Applied shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Applied Genetic. By using and applying Applied Stock analysis, traders can create a robust methodology for identifying Applied entry and exit points for their positions.
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Applied Genetic Technologies Corporation was incorporated in 1999 and is headquartered in Alachua, Florida. Applied Genetic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 83 people.

Current Applied Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Applied analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Applied analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
16.14Strong Buy7Odds
Applied Genetic Tech current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Applied analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Applied stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Applied Genetic Tech, talking to its executives and customers, or listening to Applied conference calls.
Applied Analyst Advice Details

Applied Stock Analysis Indicators

Applied Genetic Tech stock analysis indicators help investors evaluate how Applied Genetic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Applied Genetic shares will generate the highest return on investment. By understating and applying Applied Genetic stock analysis, traders can identify Applied Genetic position entry and exit signals to maximize returns.
Quick Ratio2.63
Fifty Two Week Low0.2800
Shares Short Prior Month1.36M
Average Daily Volume Last 10 Day547.39k
Average Daily Volume In Three Month1.3M
Shares Percent Shares Out2.98%
Short Percent Of Float2.99%
Forward Price Earnings-0.26
Float Shares50.5M
Fifty Two Week High3.4800
Enterprise Value To Ebitda0.40
Fifty Day Average0.4015
Two Hundred Day Average1.1576
Enterprise Value To Revenue-48.63
Please continue to Trending Equities. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for analysis

When running Applied Genetic Tech price analysis, check to measure Applied Genetic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Genetic is operating at the current time. Most of Applied Genetic's value examination focuses on studying past and present price action to predict the probability of Applied Genetic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Applied Genetic's price. Additionally, you may evaluate how the addition of Applied Genetic to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Is Applied Genetic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied Genetic. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied Genetic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Applied Genetic Tech is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied Genetic's value that differs from its market value or its book value, called intrinsic value, which is Applied Genetic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied Genetic's market value can be influenced by many factors that don't directly affect Applied Genetic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied Genetic's value and its price as these two are different measures arrived at by different means. Investors typically determine Applied Genetic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied Genetic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.